This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Imi Intelligent Medical Implants Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Vladimir Gelfandbein: Innovator in Retinal Disease Treatment
Introduction
Vladimir Gelfandbein is a notable inventor based in Mountain View, CA, who has made significant contributions to the field of medical technology. His work primarily focuses on developing innovative solutions for treating degenerative retinal diseases. With one patent to his name, Gelfandbein's inventions aim to improve the quality of life for individuals suffering from these conditions.
Latest Patents
Gelfandbein's most recent patent is titled "Mechanically Activated Objects for Treatment of Degenerative Retinal Disease." This invention involves devices designed to apply mechanical forces to the tissues of the eye, facilitating treatment for degenerative retinal diseases. The devices are configured for chronic implantation, allowing for continuous stimulation or irritation of the eye tissues. They are ideally positioned in the subretinal space and may include a moving member activated by an actuator, which can be distally located relative to the moving member.
Career Highlights
Throughout his career, Gelfandbein has worked with several prominent companies in the medical technology sector. Notable among these are Imi Intelligent Medical Implants AG and Proteus Digital Health, Inc. His experience in these organizations has contributed to his expertise in developing advanced medical devices.
Collaborations
Gelfandbein has collaborated with esteemed professionals in his field, including Alan Y Chow and George Y McLean. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in retinal treatment.
Conclusion
Vladimir Gelfandbein is a pioneering inventor whose work in mechanically activated devices for treating degenerative retinal diseases showcases his commitment to advancing medical technology. His contributions have the potential to significantly impact the lives of those affected by such conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile